These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 37879875)
1. [Identification of lymph node metastasis related genes in prostate cancer using weighted gene co-expression network analysis]. Wang HY; Li SJ; Zhang AL; Ni XC Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(40):3204-3210. PubMed ID: 37879875 [No Abstract] [Full Text] [Related]
2. Development and internal validation of a novel model and markers to identify the candidates for lymph node metastasis in patients with prostate cancer. Cao HM; Wan Z; Wu Y; Wang HY; Guan C Medicine (Baltimore); 2019 Jul; 98(30):e16534. PubMed ID: 31348270 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of hub genes for lymph node metastasis in patients with prostate cancer. Xu N; Chen SH; Lin TT; Cai H; Ke ZB; Dong RN; Huang P; Li XD; Chen YH; Zheng QS J Cell Mol Med; 2020 Apr; 24(8):4402-4414. PubMed ID: 32130760 [TBL] [Abstract][Full Text] [Related]
4. Clinical parameters and nomograms for predicting lymph node metastasis detected with Onal C; Ozyigit G; Oymak E; Guler OC; Hurmuz P; Tilki B; Reyhan M; Tuncel M; Akyol F Prostate; 2021 Jul; 81(10):648-656. PubMed ID: 33949694 [TBL] [Abstract][Full Text] [Related]
5. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection. Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120 [TBL] [Abstract][Full Text] [Related]
6. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer. Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer. Xu N; Chen HJ; Chen SH; Xue XY; Chen H; Zheng QS; Wei Y; Li XD; Huang JB; Cai H; Sun XL Medicine (Baltimore); 2016 Jul; 95(29):e4326. PubMed ID: 27442684 [TBL] [Abstract][Full Text] [Related]
8. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram. Rui X; Shao S; Wang L; Leng J BMC Cancer; 2019 Dec; 19(1):1179. PubMed ID: 31795990 [TBL] [Abstract][Full Text] [Related]
9. First Nomogram Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients Undergoing Radioisotope Guided Sentinel Lymph Node Dissection. Winter A; Kneib T; Rohde M; Henke RP; Wawroschek F Urol Int; 2015; 95(4):422-8. PubMed ID: 26159232 [TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of risk factors for bone metastasis in newly diagnosed prostate cancer patients. Peng C; Juan C; Mao W; Jinghe Y; Renli T Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3832-3839. PubMed ID: 35731052 [TBL] [Abstract][Full Text] [Related]
11. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer. Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564 [TBL] [Abstract][Full Text] [Related]
12. External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer. Roumiguié M; Beauval JB; Filleron T; Benoit T; Rischmann P; de la Taille A; Salomon L; Soulié M; Malavaud B; Ploussard G BJU Int; 2014 Dec; 114(6b):E113-E119. PubMed ID: 24684584 [TBL] [Abstract][Full Text] [Related]
13. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients. Hueting TA; Cornel EB; Somford DM; Jansen H; van Basten JA; Pleijhuis RG; Korthorst RA; van der Palen JAM; Koffijberg H Eur Urol Oncol; 2018 Oct; 1(5):411-417. PubMed ID: 31158080 [TBL] [Abstract][Full Text] [Related]
14. A novel robust nomogram based on peripheral monocyte counts for predicting lymph node metastasis of prostate cancer. Zhou JW; Mao YH; Liu Y; Liang HT; Samtani CC; Fu YW; Ye YL; Xiao G; Qin ZK; Liu CD; Yang JK; Zhou QZ; Guo WB; Xue KY; Zhao SC; Chen MK Asian J Androl; 2021; 23(4):409-414. PubMed ID: 33533737 [TBL] [Abstract][Full Text] [Related]
15. Predicting survival of patients with node-positive prostate cancer following multimodal treatment. Abdollah F; Karnes RJ; Suardi N; Cozzarini C; Gandaglia G; Fossati N; Bianchi M; Boorjian SA; Sun M; Karakiewicz PI; Montorsi F; Briganti A Eur Urol; 2014 Mar; 65(3):554-62. PubMed ID: 24094576 [TBL] [Abstract][Full Text] [Related]
16. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer]. Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201 [No Abstract] [Full Text] [Related]
17. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. Briganti A; Chun FK; Salonia A; Gallina A; Farina E; Da Pozzo LF; Rigatti P; Montorsi F; Karakiewicz PI BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698 [TBL] [Abstract][Full Text] [Related]
18. [A nomogram for predicting lymph node metastasis in early gastric cancer]. Cui H; Cao B; Deng H; Liu GB; Liang WQ; Xie TY; Ye L; Zhang QP; Wang N; Liu FD; Wei B Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):40-47. PubMed ID: 35067033 [No Abstract] [Full Text] [Related]
19. A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database. Wang M; Li R; Zou X; Wei T; Gong R; Zhu J; Li Z Medicine (Baltimore); 2020 Aug; 99(35):e21996. PubMed ID: 32871952 [TBL] [Abstract][Full Text] [Related]
20. Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection. Draulans C; Everaerts W; Isebaert S; Van Bruwaene S; Gevaert T; Oyen R; Joniau S; Lerut E; De Wever L; Laenen A; Weynand B; Defraene G; Vanhoutte E; De Meerleer G; Haustermans K J Urol; 2020 Apr; 203(4):713-718. PubMed ID: 31718396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]